However, SFR1 siRNA treatment completely abolished the estrogen-dependent growth of MCF7 cells, suggesting that SFR1 proteins are essential for ER-dependent cell proliferation and raising the possibility that SFR1 could be a therapeutic target in breast cancer (Figure 4C). This evidence concerns the gene SFR1 and breast cancer.